HbA1C GRAPH

Name: Case: Patient Type: Test Date: 2025-04-12 20:05:57

Gender: Department: Sample Type: Sample Sample Id: 12020191
Age: Year Bed no:

Peak Name Time(s) Absorbance Area Area(%) Reference Value

HbA1a 21.0 0.0022 0.164 1.2 ↑ 0.3-0.4

HbA1b 26.0 0.0007 0.068 0.5

HbF 34.0 0.0009 0.112 0.8

LA1c 49.0 0.0045 0.163 1.2

HbA1c 52.0 0.0054 0.578 4.1 ↓ 6-7

HbA0 81.0 0.4631 12.530 92.2

Total Area： 13.615

HbA1c(IFCC)=21.3mmol/mol HbA1c(NGSP)=4.1%

eAG(ADA)=70.7mg/dl eAG(ADA)=3.9mmol/l
0.03

0.025

0.02
ABS

0.015
HbA1c

0.01

0.005

0
0 20 40 60 80 100 120
Time(S)

Diagnosis:

Sender: Send Date: 2025-04-12 Report Date: 2025-04-12 20:19:03

Tester: Checker:
Comment:
Krishna Diagnostics (P) LTD
 UID: 2022147 Nationality: Indian
ITDOSE INFOSYSTEMS PVT. LTD.

Patient ID: 012504120263 Primary SampleCollection Time: 12/Apr/2025 11:53:15

Name: Ms. DURGARANI SARKAR Collection Date/Time: 12/Apr/2025 06:53PM
Age/Gender: 79 Y/Female Received Date/Time: 12/Apr/2025 06:58PM
Referred By: Dr. ARINDAM PANDE Approved Date/Time: 12/Apr/2025 08:54PM
LabID: 12020191 Print Date/Time: 12/Apr/2025 11:34PM
SpecimenType: EDTA Blood Client Grp.: KOL-131 CARE 247
DEPARTMENT OF HAEMATOLOGY
Test Description Observed Value Unit Method Biological Ref. Interval

COMPLETE HAEMOGRAM WITH ESR

Haemoglobin (Hb) 11.1* g/dL Spectophotometry 12.5-16.00
RBC Count 3.78* million/µL Electrical impedence 4.2-5.4
Packed Cell Volume 35.1* % Calculated 41-53
MCV 92.8 fL Calculated 80-100
MCH 29.4 pg Calculated 26-34
MCHC 31.7 g/dL Calculated 31-37
Platelet Count 1.65 L/cumm Impedence 1.50-4.50
TLC (Total Leucocyte Count)/WBC 5,700 /cumm Flowcytometry 4000-11000
Differential Leucocyte Count
Neutrophil 70 % Laser flowcytometry 40-80
/Microscopy
Lymphocyte 28 % Laser flowcytometry / 20-40
Microscopy
Monocytes 1* % Laser flowcytometry / 3-6
Microscopy
Eosinophils 1 % Laser flowcytometry / 01-06
Microscopy
Basophils 0 % Laser flowcytometry / 0-1
Microscopy
Absolute Neutrophil Count 3,990.0 /cumm Calculated 2000-7000
Absolute Lymphocyte Count 1,596.0 /cumm Calculated 1000-3000
Absolute Monocyte Count 57* /cumm Calculated 100-1000
Absolute Eosinophil Count 57.00 /cumm Calculated 00-500
RDW-SD 50.6* fl Cell Counter 37.0-49.0
RDW-CV 15.8 % Calculated 11.5-17.0
ESR (Westergren) 38* mm Westergren 0-20
Mean Platelet Volume 11.40* fl Calculated 8.0-11.0
NLR-Ratio 2.50 1-3 Normal
3-6 Stress
6-9 Mild Stress
9-18 Moderate Stress

Entered By:SANJIB KUMAR ADHIKARI Page 1 of 5

UID: 2022147 Nationality: Indian

Patient ID: 012504120263 Primary SampleCollection Time: 12/Apr/2025 11:53:15

Name: Ms. DURGARANI SARKAR Collection Date/Time: 12/Apr/2025 06:53PM
Age/Gender: 79 Y/Female Received Date/Time: 12/Apr/2025 06:58PM
Referred By: Dr. ARINDAM PANDE Approved Date/Time: 12/Apr/2025 08:54PM
LabID: 12020191 Print Date/Time: 12/Apr/2025 11:34PM
SpecimenType: EDTA Blood Client Grp.: KOL-131 CARE 247
DEPARTMENT OF HAEMATOLOGY
Test Description Observed Value Unit Method Biological Ref. Interval
Note: Platelet rechecked by microscopy.

*** End Of Report ***

Entered By:SANJIB KUMAR ADHIKARI Page 2 of 5

 UID: 2022147 Nationality: Indian
ITDOSE INFOSYSTEMS PVT. LTD.

Patient ID: 012504120263 Primary SampleCollection Time: 12/Apr/2025 11:53:15

Name: Ms. DURGARANI SARKAR Collection Date/Time: 12/Apr/2025 06:53PM
Age/Gender: 79 Y/Female Received Date/Time: 12/Apr/2025 06:58PM
Referred By: Dr. ARINDAM PANDE Approved Date/Time: 12/Apr/2025 08:22PM
LabID: 12020191 Print Date/Time: 12/Apr/2025 11:34PM
SpecimenType: Serum Client Grp.: KOL-131 CARE 247
DEPARTMENT OF BIOCHEMISTRY
Test Description Observed Value Unit Method Biological Ref. Interval

UREA AND CREATININE

Urea, Blood 23.3 mg/dL Urease 15-36
Serum creatinine 0.95 mg/dl enzymatic IFCC, 0.52-1.04
IDMS
Urea / Creatinine Ratio 24.53 Ratio Calculated 10.7-42.8
Sodium, Serum 145.0 mEq/L Direct ISE 135-148
Potassium, Serum 4.90 mEq/L Direct ISE 3.50-5.30

*** End Of Report ***

Entered By:SANJIB KUMAR ADHIKARI Page 3 of 5

 UID: 2022147 Nationality: Indian
ITDOSE INFOSYSTEMS PVT. LTD.

Patient ID: 012504120263 Primary SampleCollection Time: 12/Apr/2025 11:53:15

Name: Ms. DURGARANI SARKAR Collection Date/Time: 12/Apr/2025 06:53PM
Age/Gender: 79 Y/Female Received Date/Time: 12/Apr/2025 06:58PM
Referred By: Dr. ARINDAM PANDE Approved Date/Time: 12/Apr/2025 08:22PM
LabID: 12020191 Print Date/Time: 12/Apr/2025 11:34PM
SpecimenType: Whole Blood EDTA Client Grp.: KOL-131 CARE 247
DEPARTMENT OF BIOCHEMISTRY
Test Description Observed Value Unit Method Biological Ref. Interval

HbA1c(Glycated Haemoglobin) 4.1 % HPLC Non diabetic level <=5.6

Risk of diabetes 5.7 -
6.4
Diabetes >= 6.5
REMARKS
In vitro quantitative determination of HbA1c in whole blood is utilized in long term monitoring of glycemia.The HbA1c level correlates with the
mean glucose concentration prevailing in the course of the patient's recent history (approx - 6-8 weeks) and therefore provides much more reliable
information for glycemia monitoring than do determinations of blood glucose or urinary glucose. It is recommended that the determination of
HbA1c be performed at intervals of 4-6 weeks during Diabetes Mellitus therapy. Results of HbA1c should be assessed in conjunction with the
patient's medical history, clinical examinations and other findings.
Mean Plasma Glucose 70.4 mg/dl
Mean Plasma Glucose is based on estimated Average Glucose (eAG) value calculated according to National Glycohemoglobin Standardization
Program (NGSP) criteria.

Reference Range (HBA1c) : Reference Range (Average Blood Sugar):

Non diabetic level : <=5.6 % Excellent control : 90 - 120 mg/dl Action suggested : 181 - 210 mg/dl
Risk of diabetes : 5.7 - 6.4 % Good control : 121 - 150 mg/dl Panic value : > 211 mg/dl

Diabetes : >= 6.5 % Average control : 151 - 180 mg/dl

Note: Average blood sugar values is calculated from hba1c value and it indicates average blood sugar level over past three months.

*** End Of Report ***

Entered By:SANJIB KUMAR ADHIKARI Page 4 of 5

 UID: 2022147 Nationality: Indian
ITDOSE INFOSYSTEMS PVT. LTD.

Patient ID: 012504120263 Primary SampleCollection Time: 12/Apr/2025 11:53:15

Name: Ms. DURGARANI SARKAR Collection Date/Time: 12/Apr/2025 06:53PM
Age/Gender: 79 Y/Female Received Date/Time: 12/Apr/2025 06:58PM
Referred By: Dr. ARINDAM PANDE Approved Date/Time: 12/Apr/2025 08:22PM
LabID: 12020191 Print Date/Time: 12/Apr/2025 11:34PM
SpecimenType: Sod.Fluoride - PP Client Grp.: KOL-131 CARE 247
DEPARTMENT OF BIOCHEMISTRY
Test Description Observed Value Unit Method Biological Ref. Interval

Blood Glucose Fasting 86 mg/dL GOD-POD 70.0 - 110.0

Interpretation (In accordance with the American diabetes association guidelines):
· A fasting plasma glucose level below 110 mg/dL is considered normal.
· A fasting plasma glucose level between 110-126 mg/dL is considered as glucose intolerant or pre diabetic. A fasting and post-prandial blood
sugar test (after consumption of 75 gm of glucose) is recommended for all such patients.
· A fasting plasma glucose level of above 126 mg/dL is highly suggestive of a diabetic state. A repeat fasting test is strongly recommended for
all such patients. A fasting plasma glucose level in excess of 126 mg/dL on both the occasions is confirmatory of a diabetic state.

Blood Glucose Post Prandial 108 mg/dL GOD-POD 70.0-140.0

Comments:
Fasting Glucose Plasma 2 hr Plasma Glucose (mg/dL) Diagnosis
£ 99 £ 139 Normal
100 to 125 140 to 199 Pre-Diabetes
³ 126 ³ 200 Diabetes
* Confirm by repeating the test on a different day
Impaired glucose tolerance (IGT) fasting, means a person has an increased risk of developing type 2 diabetes but does not have it yet.
A level of 126 mg/dL or above, confirmed by repeating the test on another day, means a person has diabetes.
IGT (2 hrs Post meal), means a person has an increased risk of developing type 2 diabetes but does not have it yet. A 2-hour glucose
level of 200 mg/dL or above, confirmed by repeating the test on another day, means a person has diabetes

Blood Glucose Goals For people with Diabetes

Before meal 70-130 mg/dL
2 hours after meal < 180 mg/dL
HbA1c < 7%
Ref: American Diabetes association standards of medical care

Disclaimer: The test result mentioned here should be interpreted in view of clinical condition of the patient. In case of any clinical suspicion regarding any parameter, repeat test
with fresh sample essential to conclude.
*** End Of Report ***

Entered By:SANJIB KUMAR ADHIKARI Page 5 of 5